Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: Subversion of Bcl-2 by anti-oestrogens

Journal of Steroid Biochemistry and Molecular Biology

Volumn 78, Issue 5, 2001, Pages 409-418

  Burow, Matthew E ^a,b   Weldon, Christopher B ^a,b   Tang, Yan ^a,b   McLachlan, John A ^a,c   Beckman, Barbara S ^a,b  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TULANE UNIVERSITY   (United States)

Author keywords

Anti oestrogen; Apoptosis; Bcl 2; c Jun N terminal kinase; ICI 182,780; MCF 7 cells; Oestrogen; Tumour necrosis factor alpha

Indexed keywords

ANTIESTROGEN; DOXORUBICIN; ESTRADIOL; FULVESTRANT; PACLITAXEL; PROTEIN BCL 2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL SURVIVAL; DOXORUBICIN; DRUG INTERACTIONS; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; FEMALE; GENES, BCL-2; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASMS, HORMONE-DEPENDENT; PACLITAXEL; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0035660575     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(01)00117-0     Document Type: Article

References (59)

1. Dysregulation of apoptosis in cancer
2. Signal transduction during apoptosis; implications for cancer therapy
3. Hormonal control of programmed cell death/apoptosis
4. Apoptosis in the mammary gland and breast cancer
5. Morphological evaluation of cell turnover in relation to the menstrual cycle in the 'resting' human breast
6. Activation of programmed cell death in the rat ventral prostate after castration
7. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation
8. Apoptotic cell death and tissue remodelling during mouse mammary gland involution
9. Estrogen withdrawal-induced human breast cancer tumour regression in nude mice is prevented by Bcl-2
10. Time-related effects of estrogen withdrawal on proliferation- and cell death-related events in MCF-7 xenografts
11. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis
12. MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damage
13. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7
14. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells
15. Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells
16. Effects of environmental estrogens on tumor necrosis factor alpha-mediated apoptosis in MCF-7 cells
17. Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-X(L), without alteration of p53 protein levels
18. Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells
19. The pure antiestrogen ICI 182,780 is more effective in the induction of apoptosis and down regulation of Bcl-2 than tamoxifen in MCF-7 cells
20. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells
21. Overexpression of HER2 modulates Bcl-2, Bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells
22. Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells
23. 17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence
24. Role of AKT1 in 17beta-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells
25. Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons
26. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity
27. Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer
28. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium
29. The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus
30. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells
31. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD
32. Novel mechanisms of estrogen action in the brain: New players in an old story
33. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells
34. Rapid actions of plasma membrane estrogen receptors
35. Estrogen signals to the preservation of endothelial cell form and function
36. Activation of the p38 mitogen-activated protein kinase pathway by estrogen or by 4-hydroxytamoxifen is coupled to estrogen receptor-induced apoptosis
37. Cross-talk between peptide growth factor and estrogen receptor signaling pathways
38. Growth factors in breast cancer
39. Induction of apoptosis by tamoxifen and ICI 182,780 in primary breast cancer
40. Active cell death induced by the anti-estrogens tamoxifen and ICI 164,384 in human mammary carcinoma cells (MCF-7) in culture: The role of autophagy
41. Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells
42. Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells
43. Basic guide to the mechanisms of antiestrogen action
44. Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells
45. Tamoxifen induces selective membrane association of protein kinase C epsilon in MCF-7 human breast cancer cells
46. Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines
47. Recent advances in understanding the molecular mechanisms of tamoxifen action
48. Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants
49. Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions
50. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1
51. Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma
52. Inactivation of Bcl-2 by phosphorylation
53. Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1
54. Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis
55. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M
56. Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity
57. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappaB
58. Granulocyte-macrophage colony-stimulating factor rescues TF-1 leukemia cells from ionizing radiation-induced apoptosis through a pathway mediated by protein kinase Calpha
59. Activation of signal transduction kinases by tamoxifen